510(k) Report

PMA · Approved

Approved

cobas® EZH2 Mutation Test

P200014PMAApproved Jun 18, 2020108-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Molecular System, Inc. · OWD Somatic Gene Mutation Detection System

Approved on Jun 18, 2020 through premarket approval, which rests on the device’s own clinical evidence after a 108-day review.

Decided
Jun 18, 2020
Review
108 days
Class
Class III
Product code
OWD
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P200014 has 10 supplements since 2020: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2020: 12021: 12022: 12023: 42024: 12025: 12026: 1
2020high 4 (2023) · low 1 (2020)2026
View FIG. 1 as a table
YearSupplements approved
20201
20211
20221
20234
20241
20251
20261
FIG. 1 — Supplements to P200014, 2020–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OWD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All OWD devices

OWD Somatic Gene Mutation Detection System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · OWD

8in 2025

2011: 32012: 42013: 102014: 62015: 312016: 212017: 172018: 362019: 162020: 152021: 132022: 122023: 242024: 92025: 82026 (partial year): 9
2007high 36 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OWD

Too few OWD 510(k)s in any year since 2007 to give a median.

Recalls per year · OWD

2in 2022

2012: 12014: 12020: 12021: 12022: 2
2007high 2 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OWD

3in 2025

2014: 22015: 12016: 12017: 22020: 32021: 572022: 532023: 152024: 52025: 3
2007high 57 (2021) · low 0 (2007)2025

MAUDE reports naming product code OWD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20113—00
20124—10
201310—00
20146—12
201531—01
201621—01
201717—02
201836—00
201916—00
202015—13
202113—157
202212—253
202324—015
20249—05
20258—03
20269—0—
Cite this page

510(k) Report. “P200014: cobas® EZH2 Mutation Test.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P200014

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026